DAIC

JANUARY 16, 2024

Dr. Shreenivas brings his rich experience in both the clinical and commercial aspects of the structural heart landscape to his new role with Cardiac Dimensions. There, he served as an investigator in many high-profile clinical trials, including several significant structural heart studies. pivotal EMPOWER Trial,” said Dr. Shreenivas.

Bicuspid/Mitral 59

Bicuspid/Mitral Heart Failure Catheterization Laboratory Innovation 59

DAIC

AUGUST 29, 2024

Although 5G technology is not available everywhere, lead-author Xianhong Shu, also of Zhongshan Hospital, said: “This system would increase the accessibility of better medical resources as patients may travel less to get diagnosis and medical advice from cardiologists based in referral centres.”

Echocardiogram 52

Echocardiogram Bicuspid/Mitral Aortic valve Outpatient 52

DAIC

APRIL 5, 2024

New York Valves marks the next iteration of this legacy, featuring three days of transformative research and techniques that will redefine the landscape of structural heart interventions. Transcatheter valve therapy has evolved from a novel treatment for the sickest patients to become the standard of care for many with aortic stenosis.

Research 52

Research Heart Disease Best Practices Education 52

DAIC

APRIL 5, 2024

New York Valves marks the next iteration of this legacy, featuring three days of transformative research and techniques that will redefine the landscape of structural heart interventions. Transcatheter valve therapy has evolved from a novel treatment for the sickest patients to become the standard of care for many with aortic stenosis.

Heart Disease 52

Heart Disease Best Practices Education Tricuspid 52

DAIC

MAY 8, 2024

milla1cf Wed, 05/08/2024 - 11:02 May 8, 2024 — 4C Medical Technologies, Inc. ("4C 4C Medical"), a medical device company dedicated to advancing minimally invasive therapies for structural heart disease, has been granted Breakthrough Device designation by the U.S. If left untreated, MR can lead to heart failure or death.

Bicuspid/Mitral 105

Bicuspid/Mitral Technology Anatomy Heart Failure 105

DAIC

FEBRUARY 15, 2024

The device is being developed as a first-in-class implantable sensor to provide daily adjunctive objective cardiac parameter measurements enabling patients and clinicians to better manage their congestive heart failure symptoms with current medication management tools. heart failure market is projected to be $70B annually by 2030.

Heart Failure 105

Heart Failure Technology Bicuspid/Mitral Research 105

DAIC

JUNE 12, 2024

Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.

Ultrasound 105

Ultrasound Cardio Oncology Technology Congenital Heart Disease 105

DAIC

APRIL 2, 2024

MHIF was the top enroller (enrolling the first and largest number of patients) of all 68 clinical sites participating in the TRILUMINATE Pivotal trial in the United States, Canada and Europe, according to a statement issued by the Minneapolis Heart Institute Foundation on the research milestone.

Tricuspid 105

Tricuspid Heart Valves Quality of Life Open-Heart Surgery 105

Hypertension Journal

MARCH 1, 2024

After half a century of evidence suggesting the existence of mineralocorticoid receptors (MR) in the vasculature, the advent of technology to specifically knockout the MR from smooth muscle cells (SMCs) in mice has elucidated contributions of SMC-MR to cardiovascular function and disease, independent of the kidney.

Blood Pressure 40

Blood Pressure Aortic valve Heart Failure Hypertension 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Dr. S. Venkatesan MD

APRIL 3, 2025

For women with significant heart disease (e.g., severe mitral stenosis, pulmonary hypertension, or cardiomyopathy), prolonged labor could strain the heart excessively, potentially leading to decompensation, heart failure, or arrhythmias. In contrast, women with well-managed, less severe conditions (e.g.,

Heart Disease 45

Heart Disease Blood Pressure Heart Failure Aortic 45